Dr. Dinello allegedly did not comply with the recordkeeping and other requirements of the Controlled Substances Act, according to a Dec. 20 news release from the Justice Department.
Between January 2023 and August 2024, Dr. Dinello did not use the required DEA form for each distribution of a Schedule II controlled substance and failed to maintain complete and accurate records of controlled substances dispensed by him at his locations in Harrisburg and Hershey, Pa.
The settlement agreement is neither an admission of liability by Dr. Dinello nor a concession by the United States that its claims are not well founded, the release said.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
